196708-35-7 Usage
General Description
1,2-Benzisoxazole,3-chloro-5-methyl-(9CI) is a chemical compound with the molecular formula C9H6ClNO. It is a member of the benzisoxazole family, which is characterized by a benzene ring fused to an isoxazole ring. This particular compound contains a chlorine atom and a methyl group attached to the benzisoxazole ring. It is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. Additionally, it has been studied for its potential biological activities, including its anticonvulsant and antidepressant properties. The compound is also used as a ligand in coordination chemistry, where it can form complexes with various metal ions. Overall, 1,2-Benzisoxazole,3-chloro-5-methyl-(9CI) has diverse applications in the fields of medicine, agriculture, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 196708-35-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,6,7,0 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 196708-35:
(8*1)+(7*9)+(6*6)+(5*7)+(4*0)+(3*8)+(2*3)+(1*5)=177
177 % 10 = 7
So 196708-35-7 is a valid CAS Registry Number.
196708-35-7Relevant articles and documents
3-SUBSTITUTED 3,4-DIHYDRO-THIENO[2,3-D]PYRIMIDINE-4-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF
-
Page/Page column 22-23, (2008/06/13)
The invention relates to 3,4-dihydro-thieno[2,3-d]pyrimidinde-4-one-derivatives which are substituted at 3-position with 5-membered heteroaryl which can be condensed with an aryl or heteroaryl radical. The heteroaryl and, optionally, the condensed aryl or heteroaryl radical 1,2 or 3 can independently include selected substitutents from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halogen-C1-5-alkyl, halogen-C1-5alkoxy, hydroxy, -NH2, -N(R6)2, -NH(R6), aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl, the substituents aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl 1,2 or 3 independently include selected substituents from C1-5-alkythio, halogen, CN, halogen-C1-5-alkyl, halogen-C1-5alkoxy, hydroxy, -NH2, -N(R6)2 and -NH(R6). The invention also relates to the production and use of said derivatives, especially for therapeutical purposes, e.g. in the treatment of depression.
